- What is GEOC's investment thesis?
- GEOC is a China-Israel fund that invests in Israeli high-tech companies across life sciences, digital/3D printing, cybersecurity, artificial intelligence, and IoT. They aim to assist invested companies in penetrating the Chinese market and identifying strategic partners.
- Which sectors does GEOC primarily focus on for investments?
- GEOC shows a strong focus on Health Tech & Life Sciences, with 7 investment rounds and 6 portfolio companies in this sector. They also have investments in Industrial Technologies and Cyber Security.
- Can you name some of GEOC's notable portfolio companies?
- GEOC's portfolio includes companies like Insightec, which develops MR-guided focused ultrasound systems, and Highcon Systems, known for its digital cutting and creasing solutions.
- What are GEOC's most significant exits?
- GEOC had an exit in September 2025 with the acquisition of Vectorious Medical Technologies by Edwards Lifesciences for $497M. Another notable exit was Highcon Systems' IPO in November 2020, which had a valuation of $165M and raised $45M.
- Who are the managing directors at GEOC?
- The managing directors at GEOC are Shalom Tourgeman and Jacob (Yanki) Galanti.
- What investment stages does GEOC typically participate in?
- GEOC participates in a range of investment stages, including A, B, C, D, E, F, and G Rounds. Their investments show a concentration in B Round and D Round activities.
- Where is GEOC headquartered?
- GEOC is headquartered in Shanghai, China, with additional offices in Hong Kong and Tel Aviv.
